Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications on all aspects of tissue growth and regeneration. This multidisciplinary journal brings together the principles of engineering and life sciences in tissue development and regenerative medicine. Tissue Engineering provides a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable contributions to the ultimate care of patients.
The Journal is divided into three parts. Part A (the flagship) is published 24 times per year, in 12 double issues. Part B: Reviews is a bimonthly journal, and Part C: Methods has 12 monthly issues.
Tissue Engineering, Parts A, B, & C are under the editorial leadership of Co-Editors-in-Chief Antonios G. Mikos, PhD, Rice University; Peter C. Johnson, MD, Scintellix, LLC; Reviews Co-Editor-in-Chief John P. Fisher, PhD, Fischell Department of Bioengineering, University of Maryland; Methods Co-Editor-in-Chief John A. Jansen, DDS, PhD, Department of Biomaterials, Radboud University Nijmegen Medical Center; and other leading investigators. View the entire editorial board.
Various members of the editorial board are interviewed regularly and featured in the news for their breakthroughs in tissue and organ developments.
Audience: Biomedical and biomaterials engineers, materials and biomaterials scientists, stem cell researchers, biochemists, biophysicists, wound care specialists, orthopedic surgeons, and government regulators, among others.
Tissue Engineering provides “Instant Online” publication 72 hours after acceptance.
TERMIS members: Access the full text via the "Members Only" page.
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.